Gentiva, successor to Kindred at Home, has agreed to pay $19.43 million to resolve allegations that Kindred at Home knowingly submitted false claims and retained overpayments for patients who were ineligible to receive Medicare or Medicaid hospice benefits.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
